CDMO Activity Tracker: Lupin’s CDMO commissions oncology block in India; Cambrex, Axplora, Hovione expand operations

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Phytonadione, K1

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 13 USDMF, 3 CEP/COS, 4 JDMF, 4 EU WC, 1 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

33 Drugs in Development

33 Drugs in Development

FINISHED DOSAGE FORMULATIONS

101 FDF Dossiers, 35 FDA Orange Book, 17 Europe, 4 Canada, 1 Australia, 25 South Africa, 19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 10MG/ML ***Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 1MG/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 1MG/0.5ML, INJECTABLE;INJECTION - 1MG/0.5ML, INJECTABLE;INJECTION - 10MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 16 SPI Pharma, 7 DKSH, 2 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 BASF, 1 Corel Pharma Chem, 2 Finar, 8 Gangwal Chemicals, 3 Ingredion Pharma Solutions, 3 Kerry, 3 Lonza Capsugel, 8 Microlex e.U, 2 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 5 Pluviaendo, 1 Prachin Chemical, 1 Qualicaps, 15 Roquette, 9 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 3 Sigachi Industries, 1 Silverline Chemicals, 1 Valens Pharmachem, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders, 28 Parenteral, 21 Solubilizers, 18 Direct Compression, 16 Chewable & Orodispersible Aids, 15 Taste Masking, 13 Topical, 12 Thickeners and Stabilizers, 12 Lubricants & Glidants, 11 Emulsifying Agents, 10 Disintegrants & Superdisintegrants, 8 Co-Processed Excipients, 8 Film Formers & Plasticizers, 8 Empty Capsules, 7 Coating Systems & Additives, 7 Granulation, 7 Surfactant & Foaming Agents, 5 API Stability Enhancers, 2 Controlled & Modified Release, 2 Coloring Agents, 1 Rheology Modifiers

DIGITAL CONTENT

25 News #PharmaBuzz

25 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

33 APIs, 8 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Exclusivities

1 US Exclusivities

REF. STANDARDS & IMPURITIES

2 EDQM, 2 JP, 3 Others

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
29/11/2025	Enaltec Labs	India	ENALTEC LABS PRIVATE LTD	30176	PHYTONADIONE USP	2016-09-24	Active	II	Complete	2017-01-05	2016-09-23
29/11/2025	Biophore India Pharmaceuticals Pvt Ltd	India	BIOPHORE INDIA PHARMACEUTICALS PVT LTD	26447	PHYTONADIONE	2012-09-26	Active	II	N/A

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Phytonadione, K1

Phytonadione, K1

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers

13 USDMF

3 CEP/COS

4 JDMF

4 EU WC

1 NDC API

13 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

33 Drugs in Development

FINISHED DOSAGE FORMULATIONS

101 FDF Dossiers

35 FDA Orange Book

17 Europe

4 Canada

1 Australia

25 South Africa

19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 10MG/ML ***Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 1MG/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL

INJECTABLE;INJECTION - 1MG/0.5ML

INJECTABLE;INJECTION - 1MG/0.5ML

INJECTABLE;INJECTION - 10MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

16 SPI Pharma

7 DKSH

2 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 Kirsch Pharma

4 ACG Worldwide

6 Actylis

1 Aeon Procare

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 BASF

1 Corel Pharma Chem

2 Finar

8 Gangwal Chemicals

3 Ingredion Pharma Solutions

3 Kerry

3 Lonza Capsugel

8 Microlex e.U

2 Nanjing Bold Chemical

1 Nitika Pharmaceutical Specialities

5 Pluviaendo

1 Prachin Chemical

1 Qualicaps

15 Roquette

9 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

3 Sigachi Industries

1 Silverline Chemicals

1 Valens Pharmachem

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders

28 Parenteral

21 Solubilizers

18 Direct Compression

16 Chewable & Orodispersible Aids

15 Taste Masking

13 Topical

12 Thickeners and Stabilizers

12 Lubricants & Glidants

TABLET;ORAL - 5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 10MG/ML *Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 1MG/0.5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons